Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir

Zalevskaya, Alsu Gafurovna; Гафуровна, Залевская Алсу; Verbovaya, N.I. Verbovaya; Ильинична, Вербовая Нэлли; Родионова, Т. И.; Игоревна, Родионова Татьяна; Викулова, Ольга Константиновна; Константиновна, Викулова Ольга; Shestakova, Marina Vladimirovna; Владимировна, Шестакова Марина

doi:10.14341/2072-0351-5685

Cited by 2 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Однако, по данным многочисленных исследований, ночные гипогликемии до сих пор остаются серьезной проблемой на пути достижения индивидуальных целей гликемического контроля [11][12][13].…”

unclassified

Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice

et al. 2015

Self Cite

View full text Add to dashboard Cite

Цель. Оценить эффективность и безопасность лечения сахарного диабета 2 типа (СД2) с использованием нового препарата инсулина сверхдлительного действия деглудек (Тресиба®) в условиях повседневной клинической практики. Материалы и методы. В клиническом наблюдении, в условиях первичного медико-санитарного уровня, приняли участие 20 па-циентов СД2 (средний возраст -57,2 [54,4; 61,5] Federation (12.28.2012. Quality of life was assessed using the SF-36 questionnaire. All patients provided written consent before participating in the study.

show abstract

unclassified

Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

Diabetes Mellitus: The Modern State of the Issue (Part 2)

Sharofova¹,

Sagdieva²,

Yusuf³

2019

View full text Add to dashboard Cite

The authors analyzed numerous scientific studies on the problem of type 2 diabetes mellitus (T2DM), the extent of the spread is causing concern among experts around the world. The review examines and analyses the causes of the unrelated increase in the incidence of this pathology, the high risk of severe complications, comorbidities and deaths, reasons for the increase in the prevalence of the disease among children. Taking into account insufficient effectiveness of medical treatment of T2DM using synthetic drugs, the authors cites information on herbal medicine diabetes. The second part of this review provides an analysis of T2DM as a systemic disease, and analyses modern approaches to treatment pathology, issues of modern pharmacotherapy and its effectiveness, the possibility of combining pharmacotherapy and herbal medicine to improve the effectiveness of the treatment of T2DM and its complications. The review looks at the prospects for greater use of herbal medicine in diabetes to reduce the risk of severe complications, improve the quality and life expectancy of individuals, sufferers of this disease. Keywords: Type 2 diabetes, T2DM, diabetogenesis, pharmacotherapy, herbal medicine.

show abstract

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir

Abstract: Aim. To compare efficiency of two regimes of basal therapy with human insulin analogs glargin (Lantus) once daily and detemir (Levemir) twicedaily based on their hypoglycemic action (HbA1c

Cited by 2 publications

References 12 publications

Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice

Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice

Diabetes Mellitus: The Modern State of the Issue (Part 2)

Contact Info

Product

Resources

About